Elanco Animal Health draws sizable institutional investment and CEO share purchase

Defilade Capital Management L.P. increased its stake in Elanco Animal Health (NYSE: ELAN) by 132% in the first quarter, holding 931,121 shares worth about $22.3 million, or roughly 0.19% of the company. The firm’s investment now ranks as its 15th largest position. Other investors also expanded holdings, including NewEdge Advisors, Root Financial Partners, Uniplan Investment Counsel, Torren Management, and Bessemer Group, collectively raising institutional ownership to 97.48% of the stock.

In a related insider transaction, CEO Jeffrey N. Simmons bought 4,971 shares at an average price of $20.09 per share, spending $99,867 and raising his personal holding to 171,971 shares valued at approximately $3.45 million.